{
  "folder": "IC-039",
  "content": "{{knowledge objective\n|Identifiant=OIC-039-10-A\n|Item_parent=Medical assistance for procreation: the main biological, medical and ethical aspects\n|Item_parent_short=Medical assistance in procreation: the main biological, medical and ethical aspects\n|Rank=A\n|Title=Knowing the main indications for female and male fertility preservation (child, adolescent, adult)\n|Description=None\n|Rubric=Etiologies\n|Contributors=Patricia Fauque,Fabrice Guerif,Charlotte Sonigo,Geoffroy Robin,Pierre-Emmanuel Bouet,St\u00e9phanie Huberlant,Nathalie Rives\n|Order=10}}\n\nThe main medical indications for female fertility preservation are\n\n*Gonadotoxic treatments (chemotherapy, radiotherapy and surgery), used in the ''treatment'' of ''cancer'' and which can alter the stock of primordial follicles:\n**Haematological diseases (leukaemia, Hodgkin's lymphoma, non-Hodgkin's lymphoma)\n**Breast cancer\n**Other cancers\n*Gonadotoxic treatments (chemotherapy, radiotherapy and surgery), used in the \"treatment of non-cancerous pathologies\" and which may alter the stock of primordial follicles:\n**Non-malignant haematological diseases requiring chemotherapy or bone marrow transplantation.\n**Systemic diseases requiring chemotherapy\n**Ovarian diseases: bilateral benign ovarian tumours, severe or recurrent ovarian endometriosis, diseases at risk of ovarian torsion, etc.\n*Conditions at risk of premature ovarian failure: high-risk genetic anomalies (e.g. Turner syndrome, FMR1 gene pre-mutation).\n\n\nThe main medical indications for male fertility preservation are\n\n*in pubescent adolescents and adult men\n**chemotherapy or any drug treatment which may destroy spermatogonial stem cells (SSCs) or alter the sperm genome.\n**radiotherapy, which can have the same toxic effect on germ stem cells and sperm as chemotherapy if the irradiation field is close to or directly on the testicles\n**testicular surgery (e.g. testicular cancer, benign testicular tumour, testicular torsion)\n**surgery to the spermatic excretory tract, including vasectomy\n**any surgery that may result in irreversible dysfunction of erection and ejaculation (anejaculation or retrograde ejaculation) (e.g. radical prostatectomy, bladder neck surgery)\n**congenital anomalies of the testicle, most often genetic in origin, responsible for sperm damage which may worsen over time and lead to non-obstructive azoospermia (severe oligozoospermia, Klinefelter's syndrome, AZF microdeletion of the Y chromosome, etc.).\n\n*In prepubertal boys, most testicular tissue is preserved prior to allogeneic haematopoietic stem cell (HSC) transplants in the cancer field for acute leukaemia, or outside the cancer field for non-malignant haematological diseases (sickle cell anaemia, medullary aplasia, etc.), or even prior to HSC autografts for lymphomas or central nervous system tumours.",
  "question": {
    "question": "Which of the following is a primary medical indication for female fertility preservation?",
    "option_a": "Genetic predisposition to infertility",
    "option_b": "Non-malignant haematological diseases requiring chemotherapy or bone marrow transplantation",
    "option_c": "Age-related decline in fertility",
    "option_d": "Infertility due to polycystic ovary syndrome (PCOS)",
    "correct_option": "B"
  }
}